From: Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy
Cohort 1 | 12-15 months | ||||
Behaviour: spontaneous Y-maze continuous alternation, locomotor activity, Rotarod, aversive Y-maze spatial reference memory, rewarded T-maze alternation, Y-maze spatial novelty preference and rewarded Y-maze visual discrimination. | CC(9) WW(9) | ||||
↓ | |||||
Pathology: immunohistochemistry | Perfused | ||||
Cohort 2 | 4 months | 6 months | 8 months | 10 months | 12 months |
Locomotor activity | CC(93) WW(30) | CC-d(37) CC(38) WW(19) | CC-d(36) CC(37) WW(19) | CC-d(19) CC(18) WW(9) | CC-d(19) CC(18) WW(9) |
Rewarded T-maze alternation | CC(93) WW(30) | CC-d(37) CC(38) WW(19) | CC-d(36) CC(37) WW(19) | CC-d(19) CC(18) WW(9) | CC-d(19) CC(18) WW(9) |
↓ | ↓ | ↓ | |||
Y-maze spatial novelty preference | CC(16) WW(11) | CC-d(17) CC(18) WW(10) | CC-d(19) CC(18) WW(10) | ||
Aversive Y-maze spatial reference memory | CC(16) WW(11) | CC-d(17) CC(18) WW(10) | CC-d(19) CC(18) WW(10) | ||
↓ | ↓ | ↓ | |||
Immunohistochemistry and RT-qPCR | Perfused | Perfused | Perfused |